Company intelligence / Profile preview

Liberal

Cambridge, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Liberal Therapeutics is a biotechnology company focused on the development of advanced delivery systems for genetic medicines. The company leverages a proprietary high-throughput platform to engineer lipid nanoparticles (LNPs) that can effectively deliver therapeutic payloads, such as mRNA and siRNA, to organs and tissues beyond the liver. By enabling extra-hepatic delivery, Liberal Therapeutics aims to unlock the potential of genetic therapies for a wide range of previously untreatable diseases. Founded by renowned scientists from MIT and Harvard, the company is positioned at the forefront of the next generation of RNA-based therapeutics.

Therapeutic areas: Rare DiseasesOncology
Modalities: mRNA-based drugsSmall interfering RNALipid nanoparticle delivery therapyBiologic
Industry: Biotech

Beyond the preview

Go deeper on Liberal.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Liberal.

Explore the full profile